XXX - Lacidofil TM vs Placebo & Colorectal cancer (CRC)

Background:

Probiotics can potentially alleviate bowel symptoms, thereby enhancing one's quality of life (1)

Study overview:

XXX - Lacidofil vs Placebo & Colorectal cancer (CRC) is a double-blind, randomized, placebo-controlled trial evaluating Lacidofil TM or placebo in 60 enrolled patients with Colorectal cancer (CRC) (1)

Outcome measures:

The cancer-related quality of life (FACT), patient's health-9 (PHQ-9), and bowel symptoms questionnaires (1)

Results:

The administration of probiotics led to a significant reduction in the proportion of patients experiencing irritable bowel symptoms, decreasing from 67.9% at the start to 45.7% after 12 weeks, with a p-value of 0.03. Additionally, there w…